Inner retinal layer thinning in Parkinson disease

Archives of Ophthalmology

Volumn 127, Issue 6, 2009, Pages 737-741

  Hajee, Mohammedyusuf E ^a,b,c   March, Wayne F ^a,c   Lazzaro, Douglas R ^a,c   Wolintz, Arthur H ^a,b   Shrier, Eric M ^a,c   Glazman, Sofya ^a   Bodis Wollner, Ivan G ^a,b,d  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b KINGSBROOK JEWISH MEDICAL CENTER   (United States)

^c LONG ISLAND COLLEGE HOSPITAL   (United States)

^d SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; HUMAN; INNER RETINA LAYER THINNING; INTRAOCULAR PRESSURE; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA DISEASE;

DIAGNOSIS, DIFFERENTIAL; FOURIER ANALYSIS; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; NERVE FIBERS; PARKINSON DISEASE; RETINA; RETINAL DISEASES; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; TONOMETRY, OCULAR; VISUAL FIELDS;

EID: 66949160384     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.106     Document Type: Article

References (36)

1. Korell M, Tanner C. Epidemiology of Parkinson's disease. In: Ebadi M, Pfeiffer R, eds. Parkinson's Disease. New York, NY: CRC Press; 2005:39-50.
2. Parkinson J. An Essay on the Shaking Palsy. J Neuropsychiatry Clin Neurosci. 2002;14(5):223-236.
3. Appenzeller O, Goss JE. Autonomic deficits in Parkinson's syndrome. Arch Neurol. 1971;24(1):50-57.
4. Korten JJ, Meulstee J. Olfactory disturbances in Parkinsonism. Clin Neurol Neurosurg. 1980;82(2):113-118. (Pubitemid 11230145)
5. Bodis-Wollner I, Yahr MD. Measurement of visual evoked potentials in Parkinson's disease. Brain. 1978;1:661-671. (Pubitemid 9051163)
6. Bodis-Wollner I, Marx MS, Mitra S, et al. Visual dysfunction in Parkinson's disease: loss in spatiotemporal contrast sensitivity. Brain. 1987;110(pt 6):1675-1698. (Pubitemid 18152601)
7. Frederick JM, Rayborn ME, Laties AM, Lam DM, Hollyfield JG. Dopaminergic neurons in the human retina. J Comp Neurol. 1982;210(1):65-79.
8. Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci. 1990;31(11):2473-2475.
9. Djamgoz MB, Hankins MW, Hirano J, Archer SN. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res. 1997;37(24):3509-3529. (Pubitemid 27491631)
10. Ikeda H, Head GM, Ellis CJ. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res. 1994;34(19):2629-2638. (Pubitemid 24256856)
11. Sartucci F, Orlandi G, Lucetti C, et al. Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease. J Clin Neurophysiol. 2003;20(5):375-381. (Pubitemid 38031212)
12. Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol. 1996;100(1):1-11. (Pubitemid 126838501)
13. Ghilardi MF, Bodis-Wollner I, Onofrj MC, et al. Spatial frequency dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain. 1988;3:131-184. (Pubitemid 18118437)
14. Ghilardi MF, Marx MS, Bodis-Wollner I, Camras CB, Glover AA. The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Ann Neurol. 1989;25(4):357-364. (Pubitemid 19104167)
15. Schuman JS, Pedut-Kloizman T, Hertzmark E, et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology. 1996;103(11):1889-1898. (Pubitemid 26403745)
16. Blumenthal EZ, Williams JM, Weinreb RN, Girkin CA, Berry CC, Zangwill LM. Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology. 2000;107(12):2278-2282.
17. Wojtkowski M, Srinivasan V, Fujimoto J, et al. Three-dimensional retinal imaging with high speed ultrahigh resolution optical coherence tomography. Ophthalmology. 2005;112(10):1734-1746. (Pubitemid 41400010)
18. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 2004;44(24):2793-2797. (Pubitemid 39165558)
19. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol. 2008;1116:137-146. (Pubitemid 351279805)
20. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl. 1993;39:165-172. (Pubitemid 23216938)
21. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
22. Yavas GF, Yilmaz O, Küsbeci T, Oztürk F. The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. Eur J Ophthalmol. 2007;17(5):812-816.
23. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci. 1990;13(7):296-302. (Pubitemid 20193462)
24. Hutton JT, Morris JL, Elias JW. Levodopa improves spatial contrast sensitivity in Parkinson's disease. Arch Neurol. 1993;50:721-724. (Pubitemid 23203577)
25. Maffei L, Fiorentini A, Bisti S, Holländer H. Pattern ERG in the monkey after section of the optic nerve. Exp Brain Res. 1985;59(2):423-425. (Pubitemid 15029823)
26. Bobak P, Bodis-Wollner I, Harnois C, et al. Pattern electroretinograms and visualevoked potentials in glaucoma and multiple sclerosis. Am J Ophthalmol. 1983;96(1):72-83.
27. Enroth-Cugell C, Robson JG. The contrast sensitivity of retinal ganglion cells of the cat. J Physiol. 1966;187(3):517-552.
28. 2 receptor ligands on the pattern electroretinogram. Vision Res. 1998;38(10):1479-1487.
29. Bodis-Wollner I, Tzelepi A. The effect of diverse dopamine receptors on spatial processing in the central retina: a model. In: Jenkin M, Harris L, eds. Seeing Spatial Form. New York, NY: Oxford University Press; 2005: 347-367.
30. Braak H, Del Tredici K, Bratzke H, et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol. 2002;249(suppl 3):1-5.
31. Bodis-Wollner I. Diagnosing and treating early: is there a pre-cardinal stage of Parkinson disease? Parkinson Report. 2008;19:9-10.
32. Lalezary M, Medeiros FA, Weinreb RN, et al. Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects. Am J Ophthalmol. 2006;142(4):576-582. (Pubitemid 44442064)
33. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113(2):324-332. (Pubitemid 43170783)
34. Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology. 2007;69(22):2085-2092. (Pubitemid 350175711)
35. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci. 2007;48(5):2285-2289. (Pubitemid 351261307)
36. Valenti DA. Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography. Neurology. 2007;69(10):1060. (Pubitemid 47366061)